CAFs have been reported to cross-present antigen and kill CD8+T cells in an antigen-dependent manner via PD-L2 and FASL expression [147] and recruit other inhibitory immune cells to participate in suppressing anti-tumor function [61]. This evidence concerns the gene CD8A and neoplasm.